NOA rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
26-11-2017

Bahan aktif:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 10 mg)

Boleh didapati daripada:

Medis Pharma Pty Ltd

INN (Nama Antarabangsa):

rizatriptan benzoate

Borang farmaseutikal:

Tablet, orally disintegrating

Komposisi:

Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; mannitol; aspartame; calcium silicate; magnesium stearate; crospovidone; Flavour

Laluan pentadbiran:

Oral

Unit dalam pakej:

2, 6, 3

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

NOA is indicated for the acute treatment of migraine attacks with or without aura.

Ringkasan produk:

Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 5" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Status kebenaran:

Licence status A

Tarikh kebenaran:

2015-02-19